The 66 rating InvestorsObserver gives to Cellectar Biosciences Inc (CLRB) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 90 percent of stocks in the Biotechnology industry, CLRB’s 66 overall rating means the stock scores better than 66 percent of all stocks.
CLRB has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on CLRB!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Cellectar Biosciences Inc Stock Today?
Cellectar Biosciences Inc (CLRB) stock has gained 11.74% while the S&P 500 has fallen -0.19% as of 10:52 AM on Monday, Oct 2. CLRB has risen $0.31 from the previous closing price of $2.64 on volume of 189,543 shares. Over the past year the S&P 500 is up 16.35% while CLRB has fallen -12.20%. CLRB lost -$3.50 per share the over the last 12 months.
Click Here to get the full Stock Report for Cellectar Biosciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
